BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Heart
,
Biofuel
,
Lipopolysaccharide
,
rs3825942
,
ERBB2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
claudin- 10
Summary
General Info
Curated Studies
Most Correlated Studies
Kidney gene expression in claudin-16 homozygous wildtype, homozygous mutant and heterozygous mice
Colon epithelial cells from CLDN2-transgenic mice with dextran sulfate sodium-induced colitis
Retinal pigment epithelial cell gene expression during embryonic development
Liver tumor and non-tumor biopsies of patients with HCV-associated hepatocellular carcinoma
Productive and unproductive airway epithelial repair in mice exposed to naphthalene or ganciclovir
Explore Curated Studies Results
Literature
Most Relevant Literature
Claudin-10 Decrease in the Submandibular Gland Contributes to Xerostomia.
Claudin-10 overexpression suppresses human clear cell renal cell carcinoma growth and metastasis by …
CLDN10 associated with immune infiltration is a novel prognostic biomarker for clear cell renal cell…
A Novel Hypokalemic-Alkalotic Salt-Losing Tubulopathy in Patients with CLDN10 Mutations.
Immune-related key gene CLDN10 correlates with lymph node metastasis but predicts favorable prognosi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Role of Urinary Claudin-2, Caveolin-1, and EGF as Diagnostic Biomarkers of Necrotizing Enterocolitis…
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advan…
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-sm…
Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Ca…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ